A detailed history of Roberts Capital Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Roberts Capital Advisors, LLC holds 438 shares of BIIB stock, worth $64,153. This represents 0.07% of its overall portfolio holdings.

Number of Shares
438
Previous 438 -0.0%
Holding current value
$64,153
Previous $101,000 16.83%
% of portfolio
0.07%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $6,784 - $8,566
-32 Reduced 6.81%
438 $94,000
Q4 2021

Feb 15, 2022

BUY
$223.92 - $287.77 $105,242 - $135,251
470 New
470 $113,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Roberts Capital Advisors, LLC Portfolio

Follow Roberts Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roberts Capital Advisors, LLC with notifications on news.